MiNK Therapeutics Inc. (NASDAQ: INKT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MINK THERAPEUTICS INC.

MiNK Therapeutics Inc. (NASDAQ: INKT)
Listen to this Section


$12.70
-0.0500 ( -0.39% ) 0.0K

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Clinical Trial Pipeline Stages


Drug Name Stage
AgenT-797 + botensilimab/balstilimabDetailsGastroesophageal adenocarcinomas, Gastric cancer Phase 2
AgenT-797DetailsVirus-Induced Acute Respiratory Disease Syndrome Phase 1/2
AgenT-797 +/- pembrolizumab/nivolumabDetailsCOVID-19, Acute respiratory distress syndrome, Solid tumor/s, Gastric cancer, Testicular cancer, Cancer, Non-small cell lung carcinoma Phase 1
AgenT-797DetailsGraft-versus-host disease , Immune Disorders Phase 1

Market Data


Open $12.70
Previous Close $12.75
Volume 0.0K
Market Cap $63.57M
Day Range $12.61 - $13.10
52 Week Range $6.80 - $76.00
Shares Outstanding 4.98M
Change % -0.39%
Net Change ▼ -0.0500
Insider Ownership -0.02%
Exchange NASDAQ
SectorHealthcare
IndustryMedicinal Chemicals and Botanical Products
IPO Year2021
CountryUnited States
UnderwriterEvercore ISI, William Blair, B. Riley Securities, Baird, more

Insider Ownership Transactions

Total Amount Purchased: -714,279.00

Date Type Amount Purchased Purchaser
2024-06-05 Sale -15077.00 WIINBERG ULF
2024-06-05 Sale -17967.00 Corvese Brian
2024-06-05 Sale -15454.00 Behner Peter
2024-06-05 Sale -17841.00 Ryan Barbara
2024-03-05 Sale -18816.00 Corvese Brian
2024-03-05 Sale -18685.00 Ryan Barbara
2024-03-05 Sale -16185.00 Behner Peter
2024-03-05 Sale -15790.00 WIINBERG ULF
2024-01-18 Sale -15000.00 van Dijk Marcus Antonius
2024-01-18 Sale -500000.00 Buell Jennifer

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 56 Nov 14, 2025
s-3 Registration statements 18 Nov 07, 2025
4/a Other 1 Oct 03, 2025
8-k 8K-related 11 Sep 29, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Sep 11, 2025
4 Insider transactions 1 Sep 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy